- Home
- VOC vs CMRX Comparison
VOC vs CMRX Comparison
Compare VOC & CMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VOC
- CMRX
- Stock Information
- Founded
- VOC 2010
- CMRX 2000
- Country
- VOC United States
- CMRX United States
- Employees
- VOC N/A
- CMRX N/A
- Industry
- VOC Oil & Gas Production
- CMRX Biotechnology: Pharmaceutical Preparations
- Sector
- VOC Energy
- CMRX Health Care
- Exchange
- VOC Nasdaq
- CMRX Nasdaq
- Market Cap
- VOC 85.3M
- CMRX 80.7M
- IPO Year
- VOC 2011
- CMRX 2013
- Fundamental
- Price
- VOC $5.12
- CMRX $0.87
- Analyst Decision
- VOC
- CMRX Strong Buy
- Analyst Count
- VOC 0
- CMRX 1
- Target Price
- VOC N/A
- CMRX $11.00
- AVG Volume (30 Days)
- VOC 40.8K
- CMRX 137.2K
- Earning Date
- VOC 01-01-0001
- CMRX 10-31-2024
- Dividend Yield
- VOC 14.12%
- CMRX N/A
- EPS Growth
- VOC N/A
- CMRX N/A
- EPS
- VOC 0.81
- CMRX N/A
- Revenue
- VOC $14,890,701.00
- CMRX $144,000.00
- Revenue This Year
- VOC N/A
- CMRX $3,040.12
- Revenue Next Year
- VOC N/A
- CMRX N/A
- P/E Ratio
- VOC $6.25
- CMRX N/A
- Revenue Growth
- VOC N/A
- CMRX N/A
- 52 Week Low
- VOC $4.45
- CMRX $0.75
- 52 Week High
- VOC $10.36
- CMRX $1.30
- Technical
- Relative Strength Index (RSI)
- VOC 54.28
- CMRX 47.54
- Support Level
- VOC $4.96
- CMRX $0.80
- Resistance Level
- VOC $5.31
- CMRX $0.91
- Average True Range (ATR)
- VOC 0.14
- CMRX 0.05
- MACD
- VOC -0.01
- CMRX -0.00
- Stochastic Oscillator
- VOC 48.15
- CMRX 48.20
About VOC VOC Energy Trust Units of Beneficial Interest
VOC Energy Trust is a statutory trust. It is created to acquire and hold a term net profits interest for the benefit of the Trust unitholders. The underlying properties include VOC Brazos' net interests which are located in the states of Kansas and Texas. The trust is entitled to receive most of the net proceeds from the sale of production of oil and natural gas attributable to the underlying properties. The business and affairs of the Trust are managed by the Trustee, and neither VOC Brazos nor any of its affiliates has the ability to manage or influence the operations of the Trust.
About CMRX Chimerix Inc.
Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through revenue related to non-refundable upfront fees, royalties and milestone payments earned under license agreements, also by royalty revenue related to sales of TEMBEXA made by Emergent after the Asset Sale. The company operates only in one business segment namely pharmaceuticals.